Article ID Journal Published Year Pages File Type
3932026 Fertility and Sterility 2011 8 Pages PDF
Abstract
Individualization of the follicle-stimulating hormone dose according to ovarian reserve is likely to be cost effective in women who are eligible for IVF, but this effectiveness needs to be confirmed in randomized clinical trials.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Obstetrics, Gynecology and Women's Health
Preview
Cost effectiveness of ovarian reserve testing in in vitro fertilization: a Markov decision-analytic model
Authors
, , , , , , , , , , , , , , ,